Provide an overview of the multiplicity of biologic and behavioral outcomes that will need to be monitored to evaluate HPV vaccine impact, including clinical endpoints, molecular markers, and cervical cancer screening and vaccination practices. Discuss need to link disparate information and underscore the need for a coordinated approach among health department programs including cancer, immunizations, family planning, and STD as well as cancer and vaccine registries.